Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 2;55(8):432.
doi: 10.3390/medicina55080432.

Pulmonary Hypertension in COPD: A Case Study and Review of the Literature

Affiliations
Review

Pulmonary Hypertension in COPD: A Case Study and Review of the Literature

Steven J Cassady et al. Medicina (Kaunas). .

Abstract

Pulmonary hypertension (PH) is a frequently encountered complication of chronic obstructive pulmonary disease (COPD) and is associated with worsened clinical symptoms and prognosis. The prevalence of PH-COPD is not concretely established as classification criteria vary historically, but the presence of severe disease out of proportion to underlying COPD is relatively rare. Right heart catheterization, the gold standard in diagnosis of PH, is infrequently performed in COPD, and the overlap in the clinical symptoms of PH and COPD presents diagnostic challenges. Proven treatments are limited. Trials exploring the use of vasodilator therapy in this patient group generally demonstrate improvements in hemodynamics accompanied by worsening gas exchange without clearly demonstrated improvements in clinically meaningful outcomes. In-depth workup of underlying pulmonary hypertension and use of pulmonary vasodilator medications may be appropriate on an individual basis. We present a case study and a review and discussion of the pertinent literature on this topic.

Keywords: PH-COPD; chronic obstructive pulmonary disease; pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

None of the authors disclose any conflicts of interest, either real or perceived.

References

    1. Simonneau G., Montani D., Celermajer D.S., Denton C.P., Gatzoulis M.A., Krowka M., Williams P.G., Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J. 2019;53 doi: 10.1183/13993003.01913-2018. - DOI - PMC - PubMed
    1. Seeger W., Adir Y., Barberà J.A., Champion H., Coghlan J.G., Cottin V., De Marco T., Galiè N., Ghio S., Gibbs S., et al. Pulmonary hypertension in chronic lung diseases. J. Am. Coll. Cardiol. 2013;62:D109–D116. doi: 10.1016/j.jacc.2013.10.036. - DOI - PubMed
    1. Hurdman J., Condliffe R., Elliot C.A., Swift A., Rajaram S., Davies C., Hill C., Hamilton N., Armstrong I.J., Billings C., et al. Pulmonary hypertension in COPD: Results from the ASPIRE registry. Eur. Respir. J. 2013;41:1292–1301. doi: 10.1183/09031936.00079512. - DOI - PubMed
    1. Weitzenblum E., Hirth C., Ducolone A., Mirhom R., Rasaholinjanahary J., Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981;36:752–758. doi: 10.1136/thx.36.10.752. - DOI - PMC - PubMed
    1. Scharf S.M., Iqbal M., Keller C., Criner G., Lee S., Fessler H.E. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002;166:314–322. doi: 10.1164/rccm.2107027. - DOI - PubMed

MeSH terms